AdaptHealth (AHCO) Insider Bradley Coppens Buys 18,999 Shares

Insider Buying and Selling at AdaptHealth Corp.

On June 24, 2026, insider Bradley Coppens purchased 18,999 shares of AdaptHealth Corp. (NasdaqCM: AHCO) at a price of $10.29 per share. This transaction adds to a growing trend of insider buying at the company, which has recently seen multiple executives make similar purchases on the same day. The total value of this transaction was not disclosed, but it reflects a strong interest in the company's future.

Coppens was not alone in this buying spree. Other insiders, including Gregory Belinfanti, Terence Connors, Theodore Lundberg, Susan Weaver, and Williams David Solomon III, each bought 18,999 shares on the same date. This collective action shows a notable confidence among the leadership in AdaptHealth's growth prospects.

Stock Performance and Market Context

AdaptHealth's stock has fluctuated significantly over the past year, with a 52-week low of $5.21 and a high of $13.43. As of the last trading session, the stock closed at $10.29, placing it near the upper end of its yearly range. This price point may indicate positive sentiment among investors, especially following the recent insider purchases. The shares are also trading above their 50-day moving average of $7.42, suggesting a bullish momentum.

Analysts Set New Price Targets

Analysts have expressed a positive outlook on AdaptHealth. On September 17, 2026, Baird maintained an 'Outperform' rating with a price target of $9.00, down from $10.00. Similarly, UBS also maintained a 'Buy' rating with a revised target of $10.00 on August 6, 2026. RBC Capital, Truist Securities, and Jefferies have also provided favorable ratings, with Jefferies upgrading its target to $13.00 on July 21, 2026. The consensus from analysts is a 'Strong Buy,' with a target mean price of $9.00 based on seven opinions.

What AdaptHealth Corp. Does

AdaptHealth Corp. distributes home medical equipment and supplies in the United States, offering products for sleep therapy, diabetes management, and respiratory health. The company is headquartered in Conshohocken, Pennsylvania, and employs around 10,900 people. Recent insider buying may signal confidence in AdaptHealth's ability to grow its market share in the healthcare sector.

What's Ahead for AdaptHealth Corp.

AdaptHealth is set to report its next earnings on November 3, 2026. Investors will be watching for updates that could influence stock performance. The recent insider transactions reflect positions as of June 24, 2026, and may not represent current holdings. This ongoing trend of insider buying could indicate a strong belief in the company's future potential.